The global Point Of Care Breathalyzers Market was valued at USD 1.71 billion in 2022 and is expected to grow to USD 2.95 billion by 2029, at a CAGR of 8.2% during the forecast period 2023-2029.
Roche Diagnostics (Switzerland) and Danaher Corporation (US) are Leading Players in Point of Care Diagnostics Market
Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to
Point of Care Diagnostics Market worth $50.6 billion by 2025 - Exclusive Report by MarketsandMarkets™
The point of care diagnostics market offers significant growth potential for prominent as well as emerging product manufacturers
Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to
High prevalence of infectious diseases advancing the Point of Care Diagnostics Market
Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to
Point of Care Diagnostics Market : Global Opportunities By 2025
Point of Care/Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care) - Global Forecast to
Point of Care Diagnostics Market : industry Key Leaders and Growth Drivers
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024
Point of Care Diagnostics Market : Current trends and future opportunities
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024
Point of Care Diagnostics Market : Roche (Switzerland) and Siemens Healthineers (US) are the Leading Player
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024
Point of Care/POC Diagnostics Market worth $46.7 billion by 2024
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024